Abstract

The present study is to investigate the role of microRNA-21 (miR-21) in nasopharyngeal carcinoma (NPC) and the mechanisms of regulation of PTEN by miR-21. Fifty-four tissue samples were collected from 42 patients with NPC and 12 healthy controls. Human NPC cell lines CNE-1, CNE-2, TWO3 and C666-1 were used for cell assays. To investigate the expression of miR-21, RT-PCR was employed. RT-PCR, Western blotting, and immunohistochemistry were used to measure the expression of STAT3 mRNA and STAT3 protein. To test the effect of miR-21 on the cell growth and apoptosis of NPC cells in vitro, transfection of CNE1 and CNE2 cell lines and flow cytometry were performed. TUNEL assay was used to detect DNA fragmentation. To validate whether miR-21 directly recognizes the 3′-UTRs of PTEN mRNA, luciferase reporter assay was employed. miR-21 expression was increased in NPC tissues compared with control and the same result was found in NPC cell lines. Notably, increased expression of miR-21 was directly related to advanced clinical stage and lymph node metastasis. STAT3, a transcription factor activated by IL-6, directly activated miR-21 in transformed NPC cell lines. Furthermore, miR-21 markedly inhibited PTEN tumor suppressor, leading to increased AKT activity. Both in vitro and in vivo assays revealed that miR-21 enhanced NPC cell proliferation and suppressed apoptosis. miR-21, activated by STAT3, induced proliferation and suppressed apoptosis in NPC by targeting PTEN-AKT pathway.

Highlights

  • Nasopharyngeal carcinoma (NPC) causes 80,000 new cases and 50,000 deaths every year [1], [2]

  • We showed that miR-21 and STAT3 were elevated in the tissues and cell lines of NPC

  • Up-regualtion of STAT3 is responsible for the activation of miR-21 during cellular transformation

Read more

Summary

Introduction

Nasopharyngeal carcinoma (NPC) causes 80,000 new cases and 50,000 deaths every year [1], [2]. NPC is mainly a nonlymphomatous, non-keratinizing, squamous cell carcinoma, which is highly malignant with abilities of local invasion and early distant metastasis [1] Genetic susceptibility, endemic environment factors, and Epstein-Barr virus infection are believed to be the major etiologic factors of NPC [3,4,5]. The standard care for these patients consists of concurrent chemoradiotherapy with cisplatin-based regimens, generally followed by adjuvant chemotherapy. The 5-year survival rate for patients with NPC remains about 70%. Systemic and local side effects caused by chemotherapy greatly tormented the patients physically and psychologically. It is of importance to study the precise molecular mechanisms of NPC and explore new, safe and effective NPC therapies

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call